In a letter submitted to the House Energy and Commerce Subcommittee on Oversight and Investigations for a hearing on challenges implementing value-based and alternative payment models under the Medicare Access and CHIP Reauthorization Act of 2015, AHA encouraged certain statutory and regulatory policies to advance and flexibly implement these models. Recommendations include extending incentive payments; investing in resources and infrastructure to support rural hospitals’ transition to APMs; improving cost measures in the Merit-based Incentive Payment System; and supporting more gradual transitions to risk for certain Medicare Shared Savings Program accountable care organizations.  
 
“One additional factor that has impacted the transition to value-based care has been the longstanding challenges with insufficient reimbursement,” AHA said, including site-neutral payment cuts that have contributed to Medicare’s “chronic failure to cover the cost of caring for its beneficiaries.” The association said it “strongly opposes additional site-neutral payment cuts, which threaten access to care.”  

Related News Articles

Headline
The AHA July 16 filed an amicus brief in the U.S. District Court for the District of Colorado in defense of the state’s 340B contract pharmacy law prohibiting…
Headline
The U.S. District Court for the Eastern District of Missouri July 11 granted a motion by the state to dismiss claims by AbbVie that the state’s 340B contract…
Headline
The AHA July 8 wrote in opposition to the “Patient Access to Higher Quality Health Care Act” (H.R. 4002), which would repeal current law banning the creation…
Headline
The AHA July 3 released the Health Care Plan Accountability Update for the second quarter of 2025. The update covers the latest developments in Medicare…
Headline
The Departments of Justice and Health and Human Services today announced the creation of the DOJ-HHS False Claims Act Working Group to combat health care fraud…
Headline
The U.S. District Court for the Middle District of Tennessee June 30 denied a motion for a preliminary injunction by AbbVie in its lawsuit against the state’s…